Skip to content
Clinical Trials – home
NorwayBack to Norway

Clinical trials in Hønefoss – page 26

606 clinical trials in Hønefoss, Norway. Every trial is listed in the EU Clinical Trials Register and updated daily.

NorwayOur site in NorwayKliniske-Studier.no(opens in a new tab)
Hønefoss at a glance
606
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

606 trials in Hønefoss

Open in trial search

A study to evaluate the effectiveness of ispaghula husk in patients with low anterior resection syndrome after rectal cancer surgery

Registered drug
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Ispaghula husk
  • Sponsor:Sykehuset Telemark HF

Effect of Dexmedetomidine vs Sodium Chloride on Emergence Delirium in Children Aged 1‑7 Years Undergoing Adenotonsillectomy

Registered drug
Countries:NorwayNorway
  • Participants:0–17 years
  • Substances:Dexmedetomidine
  • Sponsor:Akershus University Hospital

Migraine

Not yet recruiting

A study to evaluate the safety and effectiveness of omalizumab in adults with episodic migraine

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years
  • Substances:Omalizumab
  • Sponsor:Oslo University Hospital HF

Plasma cell myeloma

Not yet recruiting

A study of etentamig and daratumumab compared to daratumumab, lenalidomide, and dexamethasone in adults with newly diagnosed multiple myeloma not eligible for transplant

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Daratumumab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Glioblastoma

Not yet recruiting

Phase 3 Randomized Study of Niraparib Tosilate Monohydrate vs. Temozolomide in Newly Diagnosed MGMT Unmethylated Glioblastoma

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Temozolomide
  • Sponsor:Neurotrials LLC
Countries:NorwayNorway
  • Participants:18–64 years · Healthy volunteers
  • Substances:Paracetamol
  • Sponsor:Oslo Metropolitan University

Cluster headache

Not yet recruiting

A Study of Candesartan to Prevent Chronic Cluster Headache Attacks in Adults with Chronic Cluster Headache

Registered drug
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Candesartan
  • Sponsor:Helse Bergen HF

Cluster headache

Not yet recruiting

A Study of Candesartan Compared to Placebo in Adults with Episodic Cluster Headache to Prevent Severe Headache Attacks

Registered drug
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Candesartan
  • Sponsor:Helse Bergen HF

Study of mezigdomide and elranatamab combination treatment for patients with relapsed or refractory multiple myeloma

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Dexamethasone
  • Sponsor:Celgene Corp.

Multiple sclerosis

Not yet recruiting

Study of Tenofovir Alafenamide as Add-on Treatment to Anti-CD20 Therapy in Multiple Sclerosis Patients to Reduce Neuronal Damage

Registered drug
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Tenofovir Alafenamide
  • Sponsor:Oslo University Hospital HF

Analgesic therapy

Not yet recruiting

Evaluating the effectiveness of icatibant in reducing propofol injection pain in healthy adult volunteers

Registered drug
Countries:NorwayNorway
  • Participants:18–64 years · Healthy volunteers
  • Substances:Icatibant
  • Sponsor:Oslo University Hospital HF

Critical illness

Not yet recruiting

Study on Midazolam Hydrochloride: Comparing Subcutaneous and Intravenous Use in Adults with Terminal Illness in Palliative Care

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Midazolam Hydrochloride
  • Sponsor:Akershus University Hospital

Other cities in Norway

The busiest research cities in the country

All 53 cities in Norway

Clinical research in Hønefoss

What the registry says about research in the country

01 Musculoskeletal Diseases

In Hønefoss, researchers are evaluating non‑pharmacologic and medication approaches for acute neck pain. The study compares chiropractic spinal manipulative therapy with standard use of NSAIDs to determine which method best reduces pain intensity during the treatment period.

  • Comparative effectiveness of manual therapy versus medication
  • Measurement of pain intensity and functional recovery
  • Patient‑reported outcome measures
  • Safety and feasibility of combined treatment strategies

Findings aim to guide clinicians in selecting optimal first‑line interventions for neck pain, potentially improving recovery speed and patient satisfaction.

02 Bacterial Infections and Mycoses

Clinical investigators are studying patients with suspected community‑acquired sepsis to assess whether a regimen of narrow spectrum β‑lactam antibiotics together with an aminoglycoside is safe and non‑inferior to standard broad spectrum antibiotics. The goal is to refine early treatment choices while minimizing unnecessary broad‑spectrum exposure.

  • Early antibiotic stewardship in severe infections
  • Safety profiling of combination therapy
  • Efficacy comparison with broad‑spectrum regimens
  • Impact on patient outcomes and hospital stay

Results could support more targeted antibiotic use, preserving effectiveness of broad‑spectrum agents and reducing resistance development.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.